BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38419308)

  • 21. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of PTEN in regulation of hepatic macrophages activation and function in progression and reversal of liver fibrosis.
    Cheng Y; Tian Y; Xia J; Wu X; Yang Y; Li X; Huang C; Meng X; Ma T; Li J
    Toxicol Appl Pharmacol; 2017 Feb; 317():51-62. PubMed ID: 28095306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic plasticity of macrophage functions in diseased liver.
    Ritz T; Krenkel O; Tacke F
    Cell Immunol; 2018 Aug; 330():175-182. PubMed ID: 29454647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Myeloid-Derived Cells in the Progression of Liver Disease.
    Weston CJ; Zimmermann HW; Adams DH
    Front Immunol; 2019; 10():893. PubMed ID: 31068952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy-deficient Kupffer cells promote tumorigenesis by enhancing mtROS-NF-κB-IL1α/β-dependent inflammation and fibrosis during the preneoplastic stage of hepatocarcinogenesis.
    Sun K; Xu L; Jing Y; Han Z; Chen X; Cai C; Zhao P; Zhao X; Yang L; Wei L
    Cancer Lett; 2017 Mar; 388():198-207. PubMed ID: 28011320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of heterogenous hepatic macrophages in the progression of liver diseases.
    Lee KJ; Kim MY; Han YH
    BMB Rep; 2022 Apr; 55(4):166-174. PubMed ID: 35321784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage in liver Fibrosis: Identities and mechanisms.
    Wang Z; Du K; Jin N; Tang B; Zhang W
    Int Immunopharmacol; 2023 Jul; 120():110357. PubMed ID: 37224653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
    Matsuda M; Seki E
    Semin Liver Dis; 2020 Aug; 40(3):307-320. PubMed ID: 32242330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophages as key regulators of liver health and disease.
    Papachristoforou E; Ramachandran P
    Int Rev Cell Mol Biol; 2022; 368():143-212. PubMed ID: 35636927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.
    Xu J; Liu X; Koyama Y; Wang P; Lan T; Kim IG; Kim IH; Ma HY; Kisseleva T
    Front Pharmacol; 2014; 5():167. PubMed ID: 25100997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis.
    Su SB; Qin SY; Xian XL; Huang FF; Huang QL; ZhangDi HJ; Jiang HX
    Life Sci; 2021 Jan; 264():118677. PubMed ID: 33129875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver macrophages in healthy and diseased liver.
    Abdullah Z; Knolle PA
    Pflugers Arch; 2017 Apr; 469(3-4):553-560. PubMed ID: 28293730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infusion of Kupffer Cells Expanded in
    Li W; He F
    Cell Transplant; 2021; 30():9636897211004090. PubMed ID: 33784833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-cellular transitional organotypic models to investigate liver fibrosis.
    Orbach SM; Ford AJ; Saverot SE; Rajagopalan P
    Acta Biomater; 2018 Dec; 82():79-92. PubMed ID: 30316024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis.
    Wallace K; Burt AD; Wright MC
    Biochem J; 2008 Apr; 411(1):1-18. PubMed ID: 18333835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver inflammation and fibrosis.
    Koyama Y; Brenner DA
    J Clin Invest; 2017 Jan; 127(1):55-64. PubMed ID: 28045404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of hepatic macrophages in liver metastasis.
    Keirsse J; Van Damme H; Geeraerts X; Beschin A; Raes G; Van Ginderachter JA
    Cell Immunol; 2018 Aug; 330():202-215. PubMed ID: 29661474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic stellate cell-intrinsic role of SOCS1 in controlling hepatic fibrogenic response and the pro-inflammatory macrophage compartment during liver fibrosis.
    Kandhi R; Yeganeh M; Yoshimura A; Menendez A; Ramanathan S; Ilangumaran S
    Front Immunol; 2023; 14():1259246. PubMed ID: 37860002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin reduces Ly6C
    Zhao XA; Chen G; Liu Y; Chen Y; Wu H; Xiong Y; Wang G; Jia B; Li Y; Xia J; Wang J; Yan X; Zhang Z; Huang R; Wu C
    Biomed Pharmacother; 2018 Oct; 106():868-878. PubMed ID: 30119257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.